Historical Valuation
ProMIS Neurosciences Inc (PMN) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -1.10. The fair price of ProMIS Neurosciences Inc (PMN) is between -- to -- according to relative valuation methord.
Relative Value
Fair Zone
-----
Current Price：8.13
Fair
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
ProMIS Neurosciences Inc (PMN) has a current Price-to-Book (P/B) ratio of 1.67. Compared to its 3-year average P/B ratio of 33.74 , the current P/B ratio is approximately -95.05% higher. Relative to its 5-year average P/B ratio of 21.98, the current P/B ratio is about -92.39% higher. ProMIS Neurosciences Inc (PMN) has a Forward Free Cash Flow (FCF) yield of approximately -179.40%. Compared to its 3-year average FCF yield of -71.82%, the current FCF yield is approximately 149.80% lower. Relative to its 5-year average FCF yield of -50.94% , the current FCF yield is about 252.16% lower.
P/B
Median3y
33.74
Median5y
21.98
FCF Yield
Median3y
-71.82
Median5y
-50.94
Competitors Valuation Multiple
AI Analysis for PMN
The average P/S ratio for PMN competitors is 6.03, providing a benchmark for relative valuation. ProMIS Neurosciences Inc Corp (PMN.O) exhibits a P/S ratio of 0.00, which is -100% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
Performance Decomposition
AI Analysis for PMN
1Y
3Y
5Y
Market capitalization of PMN increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of PMN in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is PMN currently overvalued or undervalued?
ProMIS Neurosciences Inc (PMN) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -1.10. The fair price of ProMIS Neurosciences Inc (PMN) is between to according to relative valuation methord.
What is ProMIS Neurosciences Inc (PMN) fair value?
PMN's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of ProMIS Neurosciences Inc (PMN) is between to according to relative valuation methord.
How does PMN's valuation metrics compare to the industry average?
The average P/S ratio for PMN's competitors is 6.03, providing a benchmark for relative valuation. ProMIS Neurosciences Inc Corp (PMN) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
What is the current P/B ratio for ProMIS Neurosciences Inc (PMN) as of Jan 10 2026?
As of Jan 10 2026, ProMIS Neurosciences Inc (PMN) has a P/B ratio of 1.67. This indicates that the market values PMN at 1.67 times its book value.
What is the current FCF Yield for ProMIS Neurosciences Inc (PMN) as of Jan 10 2026?
As of Jan 10 2026, ProMIS Neurosciences Inc (PMN) has a FCF Yield of -179.40%. This means that for every dollar of ProMIS Neurosciences Inc’s market capitalization, the company generates -179.40 cents in free cash flow.
What is the current Forward P/E ratio for ProMIS Neurosciences Inc (PMN) as of Jan 10 2026?
As of Jan 10 2026, ProMIS Neurosciences Inc (PMN) has a Forward P/E ratio of -0.69. This means the market is willing to pay $-0.69 for every dollar of ProMIS Neurosciences Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for ProMIS Neurosciences Inc (PMN) as of Jan 10 2026?
As of Jan 10 2026, ProMIS Neurosciences Inc (PMN) has a Forward P/S ratio of 0.00. This means the market is valuing PMN at $0.00 for every dollar of expected revenue over the next 12 months.